The White House Office of National Drug Control Policy seeks by 2022 to reduce drug overdose deaths and youth illicit drug use by 15 percent and opioid prescription fills by one third, according to goals released Friday for its National Drug Control Strategy. Among other goals for 2022, the office aims to have 20 percent of specialty treatment facilities providing medication-assisted treatment, 10 percent of practitioners certified to prescribe and dispense buprenorphine for opioid use disorder, and 72 percent of federal prescribers complete continuing education on opioid best practices and clinical guidelines. It also aims to increase to 30 the number of states integrating electronic health records with their prescription drug monitoring programs. The office released its National Drug Control Strategy in February to guide federal efforts to reduce the availability and use of illicit drugs and barriers to substance use disorder treatment.

Related News Articles

Headline
Oct. 28 is National Prescription Drug Take Back Day, an opportunity for the public to safely dispose of unwanted or expired tablets, capsules, patches and…
Headline
Federal agencies last month stopped over 500 unapproved pharmaceutical products and medical devices, including opioid and other controlled substances, from…
Headline
As the House Energy and Commerce Committee works to reauthorize key programs within the Substance Use-Disorder Prevention that Promotes Opioid Recovery and…
Headline
While counseling and other services are an important part of a comprehensive treatment plan for opioid use disorder, the provision of medication should not be…
Headline
AHA today launched an updated Opioid Stewardship Hub, featuring the latest tools and resources to help hospitals and health systems address the opioid epidemic…
Headline
The Food and Drug Administration last week required certain labeling updates for opioid pain medicines in an effort to reduce unnecessary prescribing and…